Suspension of trading

Income Statement Exact Sciences Corporation

Stocks

EXAS

US30063P1057

Biotechnology & Medical Research

Delayed Nasdaq 01:30:00 21/03/2026 am IST			5-day change	1st Jan Change
104.91 ^USD	+0.95%		-.--%	+3.30%

25/03	Exact Sciences Corporation(NasdaqCM:EXAS) dropped from S&P Biotechnology Select Industry Index	CI
25/03	Exact Sciences Corporation(NasdaqCM:EXAS) dropped from S&P Global BMI Index	CI

d05e981df9b0ab.DfIPW8QLuzpOYbk67hK3Sb--ZdWXS8fsn1l00PuA4_g.X6NLEY057F4WU_J_lyOHf4bzVKClAYi-wAtG_Y7UooFkwWw5ikjZTRcy8A

Published financial data: EXACT SCIENCES CORPORATION

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021 (USD)	2022 (USD)	2023 (USD)	2024 (USD)	2025 (USD)
Revenues	176.71Cr	208.43Cr	249.98Cr	275.89Cr	324.7Cr
Total Revenues	176.71Cr	208.43Cr	249.98Cr	275.89Cr	324.7Cr
Cost of Goods Sold, Total	46Cr	57Cr	65Cr	84Cr	98Cr
Gross Profit	130.83Cr	150.99Cr	184.55Cr	191.87Cr	226.28Cr
Selling General & Admin Expenses, Total	151.62Cr	163.99Cr	163.83Cr	167.93Cr	189.05Cr
R&D Expenses	39Cr	39Cr	43Cr	43Cr	52Cr
Amortization of Goodwill and Intangible Assets - (IS)	9.5Cr	9.74Cr	9.22Cr	-	-
Other Operating Expenses	-	-	-20.27L	-	-
Other Operating Expenses, Total	199.68Cr	213.08Cr	215.44Cr	211.05Cr	241.3Cr
Operating Income	-69Cr	-62Cr	-31Cr	-19Cr	-15Cr
Interest Expense, Total	-1.86Cr	-1.96Cr	-1.94Cr	-2.7Cr	-3.94Cr
Interest And Investment Income	3.18Cr	-	3.27Cr	3.96Cr	4.18Cr
Net Interest Expenses	1.32Cr	-1.96Cr	1.33Cr	1.25Cr	24.1L
EBT, Excl. Unusual Items	-68Cr	-64Cr	-30Cr	-18Cr	-15Cr
Restructuring Charges	-	-	-	-	-2.22Cr
Merger & Related Restructuring Charges	-14Cr	-	-	-	-
Gain (Loss) On Sale Of Investments	-	-1.94Cr	-	-	-
Gain (Loss) On Sale Of Assets	-	-1.32Cr	-	-	-
Asset Writedown	-2.02Cr	-1.6Cr	-6L	-87Cr	-72L
Other Unusual Items	-63.59L	5.66Cr	9.44Cr	1.25Cr	-2.68Cr
EBT, Incl. Unusual Items	-84Cr	-63Cr	-20Cr	-103.62Cr	-20Cr
Income Tax Expense	-25Cr	-90.64L	24.03L	-73.04L	40.61L
Earnings From Continuing Operations	-60Cr	-62Cr	-20Cr	-102.89Cr	-21Cr
Net Income to Company	-60Cr	-62Cr	-20Cr	-102.89Cr	-21Cr
Net Income - (IS)	-60Cr	-62Cr	-20Cr	-102.89Cr	-21Cr
Net Income to Common Incl Extra Items	-60Cr	-62Cr	-20Cr	-102.89Cr	-21Cr
Net Income to Common Excl. Extra Items	-60Cr	-62Cr	-20Cr	-102.89Cr	-21Cr
Per Share Items
Net EPS - Basic	-3.48	-3.54	-1.13	-5.59	-1.1
Basic EPS - Continuing Operations	-3.48	-3.54	-1.13	-5.59	-1.1
Basic Weighted Average Shares Outstanding	17Cr	18Cr	18Cr	18Cr	19Cr
Net EPS - Diluted	-3.48	-3.54	-1.13	-5.59	-1.1
Diluted EPS - Continuing Operations	-3.48	-3.54	-1.13	-5.59	-1.1
Diluted Weighted Average Shares Outstanding	17Cr	18Cr	18Cr	18Cr	19Cr
Normalized Basic EPS	-2.46	-2.27	-1.03	-0.61	-0.49
Normalized Diluted EPS	-2.46	-2.27	-1.03	-0.61	-0.49
American Depositary Receipts Ratio (ADR)	0.1	0.1	0.1	0.1	0.1
Supplemental Items
EBITDA	-51Cr	-42Cr	-10Cr	2.31Cr	7.15Cr
EBITA	-59Cr	-52Cr	-22Cr	-9.66Cr	-5.34Cr
EBIT	-69Cr	-62Cr	-31Cr	-19Cr	-15Cr
EBITDAR	-47Cr	-38Cr	-5.65Cr	6.5Cr	11Cr
Total Revenues (As Reported)	-	-	-	-	-
Effective Tax Rate - (Ratio)	29.3	1.43	-1.19	0.7	-1.99
Current Domestic Taxes	13.88L	21.7L	22.66L	9L	15.16L
Current Foreign Taxes	48.98L	11.31L	25.61L	18.82L	39.09L
Total Current Taxes	62.86L	33.01L	48.27L	28.15L	54.25L
Deferred Domestic Taxes	-25Cr	-1.22Cr	6L	-99.2L	2L
Deferred Foreign Taxes	54T	-1L	-29.9L	-2L	-15.28L
Total Deferred Taxes	-25Cr	-1.24Cr	-24.24L	-1.01Cr	-13.64L
Normalized Net Income	-42Cr	-40Cr	-18Cr	-11Cr	-9.23Cr
Interest on Long-Term Debt	1.72Cr	1.69Cr	2.43Cr	3.4Cr	3.39Cr
Supplemental Operating Expense Items
Advertising Expense	14Cr	17Cr	14Cr	18Cr	20Cr
Marketing Expenses	19Cr	24Cr	18Cr	21Cr	-
Selling and Marketing Expenses	86Cr	85Cr	73Cr	89Cr	104.73Cr
General and Administrative Expenses	65Cr	79Cr	91Cr	79Cr	84Cr
Research And Development Expense From Footnotes	47Cr	39Cr	43Cr	43Cr	52Cr
Net Rental Expense, Total	3.76Cr	4.48Cr	4.58Cr	4.19Cr	4.2Cr
Imputed Operating Lease Interest Expense	23.54L	28.93L	28.35L	33.89L	49.85L
Imputed Operating Lease Depreciation	3.52Cr	4.19Cr	4.29Cr	3.85Cr	3.7Cr
Stock-Based Comp., COGS (Total)	-	1.92Cr	2.08Cr	2.05Cr	1.72Cr
Stock-Based Comp., R&D Exp. (Total)	-	3.38Cr	4.12Cr	3.97Cr	3.74Cr
Stock-Based Comp., S&M Exp. (Total)	-	6.26Cr	6.56Cr	6.82Cr	6.68Cr
Stock-Based Comp., G&A Exp. (Total)	-	9.12Cr	10Cr	8.64Cr	9.63Cr
Stock-Based Comp., Other (Total)	25Cr	-	-	-	-
Total Stock-Based Compensation	25Cr	21Cr	23Cr	21Cr	22Cr

Fiscal Period: December	2021 (USD)	2022 (USD)	2023 (USD)	2024 (USD)	2025 (USD)
Assets
Cash And Equivalents	32Cr	24Cr	61Cr	60Cr	96Cr
Short Term Investments	72Cr	39Cr	17Cr	44Cr	87.15L
Total Cash And Short Term Investments	103.05Cr	63Cr	78Cr	103.8Cr	96Cr
Accounts Receivable, Total	22Cr	16Cr	20Cr	25Cr	30Cr
Other Receivables	32L	55L	38L	-	-
Total Receivables	22Cr	16Cr	21Cr	25Cr	30Cr
Inventory	10Cr	12Cr	13Cr	16Cr	17Cr
Prepaid Expenses	7.09Cr	6.81Cr	8.18Cr	9.41Cr	9.65Cr
Restricted Cash	-	3L	-	-	-
Other Current Assets, Total	-	-	-	2.79Cr	2.98Cr
Total Current Assets	142.62Cr	98Cr	119.44Cr	157.14Cr	155.58Cr
Gross Property Plant And Equipment	98Cr	115.96Cr	127.06Cr	133.9Cr	144.62Cr
Accumulated Depreciation	-21Cr	-31Cr	-42Cr	-51Cr	-60Cr
Net Property Plant And Equipment	76Cr	85Cr	85Cr	83Cr	84Cr
Long-term Investments	2.68Cr	4.37Cr	5.12Cr	5.79Cr	6.28Cr
Goodwill	233.52Cr	234.6Cr	236.71Cr	236.67Cr	236.8Cr
Other Intangibles, Total	210.5Cr	196.62Cr	189.04Cr	100.97Cr	92Cr
Accounts Receivable Long-Term	-	-	4.17Cr	2.59Cr	-
Other Long-Term Assets, Total	2.96Cr	3.67Cr	7.32Cr	6.61Cr	11Cr
Total Assets	668.49Cr	622.69Cr	647.13Cr	592.81Cr	586.06Cr
Liabilities
Accounts Payable, Total	6.78Cr	7.49Cr	7.88Cr	8.96Cr	18Cr
Accrued Expenses, Total	37Cr	28Cr	32Cr	31Cr	39Cr
Current Portion of Long-Term Debt	-	-	5Cr	25Cr	-
Current Portion of Leases	2.59Cr	3.16Cr	3.38Cr	3.63Cr	3.99Cr
Current Income Taxes Payable	-	-	-	-	-
Unearned Revenue Current, Total	10L	31L	-	-	-
Other Current Liabilities	4.96Cr	1.84Cr	2.76Cr	5.12Cr	3.66Cr
Total Current Liabilities	52Cr	41Cr	51Cr	73Cr	64Cr
Long-Term Debt	218.02Cr	223.61Cr	231.43Cr	232.11Cr	232.72Cr
Long-Term Leases	19Cr	19Cr	17Cr	17Cr	17Cr
Deferred Tax Liability Non Current	2.88Cr	1.97Cr	1.73Cr	72L	58L
Other Non Current Liabilities	38Cr	33Cr	31Cr	30Cr	32Cr
Total Liabilities	329.72Cr	318.37Cr	332.6Cr	352.59Cr	345.96Cr
Common Stock, Total	17.38L	17.8L	18.15L	18.57L	19.09L
Additional Paid In Capital	602.89Cr	631.16Cr	661.12Cr	689.94Cr	710.28Cr
Retained Earnings	-264.15Cr	-326.5Cr	-346.92Cr	-449.8Cr	-470.6Cr
Comprehensive Income and Other	-14.43L	-52.36L	14.28L	-9L	23.58L
Total Common Equity	338.76Cr	304.32Cr	314.53Cr	240.22Cr	240.11Cr
Total Equity	338.76Cr	304.32Cr	314.53Cr	240.22Cr	240.11Cr
Total Liabilities And Equity	668.49Cr	622.69Cr	647.13Cr	592.81Cr	586.06Cr
Supplemental Items
ECS Total Shares Outstanding on Filing Date	17Cr	18Cr	18Cr	19Cr	19Cr
ECS Total Common Shares Outstanding	17Cr	18Cr	18Cr	19Cr	19Cr
Book Value / Share	19.51	17.1	17.34	12.94	12.58
Tangible Book Value	-105.25Cr	-126.91Cr	-111.22Cr	-97Cr	-89Cr
Tangible Book Value Per Share	-6.06	-7.13	-6.13	-5.25	-4.65
Total Debt	240.08Cr	245.75Cr	256.66Cr	277.57Cr	253.48Cr
Net Debt	137.04Cr	182.54Cr	178.9Cr	173.77Cr	157.01Cr
Debt Equivalent Oper. Leases	30Cr	36Cr	37Cr	34Cr	34Cr
Account Code - Inventory Valuation	5	5	5	5	5
Inventories - Raw Materials, Total	5.13Cr	6.12Cr	5.86Cr	6.97Cr	7.57Cr
Inventories - Work In Process, Total	5.37Cr	5.71Cr	6.89Cr	9.27Cr	9.05Cr
Land - (BS)	47.16L	47.16L	47.16L	47.16L	47.16L
Buildings, Total	21Cr	29Cr	29Cr	29Cr	29Cr
Machinery, Total	33Cr	42Cr	49Cr	58Cr	67Cr
Full Time Employees	6.42T	6.3T	6.5T	6.9T	7.1T
Part Time Employees	80	100	100	100	100

Fiscal Period: December	2021 (USD)	2022 (USD)	2023 (USD)	2024 (USD)	2025 (USD)
Net Income	-60Cr	-62Cr	-20Cr	-102.89Cr	-21Cr
Depreciation & Amortization - CF	8.53Cr	10Cr	11Cr	12Cr	12Cr
Amortization of Goodwill and Intangible Assets - (CF)	9.5Cr	9.74Cr	9.22Cr	9.52Cr	9.67Cr
Depreciation & Amortization, Total	18Cr	20Cr	21Cr	21Cr	22Cr
Amortization of Deferred Charges, Total - (CF)	66.83L	71.27L	-	-	-
(Gain) Loss From Sale Of Asset	10.55L	1.51Cr	-	-	-
(Gain) Loss on Sale of Investments - (CF)	-2.44Cr	2.36Cr	-40.98L	27.13L	-30.81L
Asset Writedown & Restructuring Costs	11Cr	1.6Cr	11.21L	87Cr	8.22Cr
Stock-Based Compensation (CF)	25Cr	21Cr	23Cr	21Cr	22Cr
Other Operating Activities, Total	-14Cr	-3.99Cr	-7.43Cr	-65.12L	5.92Cr
Change In Accounts Receivable	2.52Cr	6.11Cr	-4.34Cr	-4.63Cr	-4.89Cr
Change In Inventories	-92.21L	-1.32Cr	-76.9L	-3.49Cr	-37.72L
Change In Accounts Payable	17Cr	-5.22Cr	8.28Cr	4.35Cr	21Cr
Change in Other Net Operating Assets	-7.46Cr	-2.21Cr	-3.2Cr	-1.84Cr	-3.96Cr
Cash from Operations	-10Cr	-22Cr	16Cr	21Cr	49Cr
Capital Expenditure	-14Cr	-21Cr	-12Cr	-14Cr	-13Cr
Sale of Property, Plant, and Equipment	-	2.5Cr	-	-	-
Cash Acquisitions	-56Cr	-1.47Cr	-5.29Cr	-4.5Cr	-7.5Cr
Sale (Purchase) of Intangible assets	-	-	-	-	-
Investment in Marketable and Equity Securities, Total	-39Cr	28Cr	23Cr	-26Cr	38Cr
Other Investing Activities, Total	-7L	-5L	2L	-2L	2.83Cr
Cash from Investing	-108.21Cr	7.41Cr	4.97Cr	-44Cr	20Cr
Long-Term Debt Issued, Total	-	-	14Cr	27Cr	-
Total Debt Issued	-	-	14Cr	27Cr	-
Long-Term Debt Repaid, Total	-2.37Cr	-	-	-5Cr	-25Cr
Total Debt Repaid	-2.37Cr	-	-	-5Cr	-25Cr
Issuance of Common Stock	3.75Cr	3.2Cr	3.15Cr	3.29Cr	2.84Cr
Other Financing Activities, Total	-52.86L	4.45Cr	-97.51L	-1.78Cr	-12Cr
Cash from Financing	84.72L	7.65Cr	16Cr	23Cr	-34Cr
Foreign Exchange Rate Adjustments	23T	30T	13.21L	-32.94L	9L
Net Change in Cash	-117.58Cr	-7.3Cr	37Cr	-30.39L	35Cr
Supplemental Items
Cash Interest Paid	1.07Cr	1.15Cr	1.88Cr	2.78Cr	3.04Cr
Levered Free Cash Flow	1.35Cr	-27Cr	9.18Cr	5.62Cr	28Cr
Unlevered Free Cash Flow	1.85Cr	-26Cr	10Cr	7.31Cr	31Cr
Change In Net Working Capital	-15Cr	6.44Cr	1.68Cr	10Cr	-9.57Cr
Net Debt Issued / Repaid	-2.37Cr	-	14Cr	22Cr	-25Cr

Fiscal Period: December	2021 (USD)	2022 (USD)	2023 (USD)	2024 (USD)	2025 (USD)
Profitability
Return on Assets	-7.41	-6.01	-3.04	-1.93	-1.59
Return on Total Capital	-8.3	-6.88	-3.44	-2.2	-1.86
Return On Equity %	-21.18	-19.39	-6.6	-37.09	-8.66
Return on Common Equity	-21.18	-19.39	-6.6	-37.09	-8.66
Margin Analysis
Gross Profit Margin %	74.04	72.44	73.83	69.55	69.69
SG&A Margin	85.8	78.68	65.54	60.87	58.22
EBITDA Margin %	-28.76	-20.31	-4.09	0.84	2.2
EBITA Margin %	-33.59	-25.11	-8.67	-3.5	-1.65
EBIT Margin %	-38.96	-29.79	-12.35	-6.95	-4.62
Income From Continuing Operations Margin %	-33.71	-29.91	-8.17	-37.29	-6.4
Net Income Margin %	-33.71	-29.91	-8.17	-37.29	-6.4
Net Avail. For Common Margin %	-33.71	-29.91	-8.17	-37.29	-6.4
Normalized Net Income Margin	-23.89	-19.21	-7.39	-4.06	-2.84
Levered Free Cash Flow Margin	0.76	-12.84	3.67	2.04	8.68
Unlevered Free Cash Flow Margin	1.04	-12.6	4.16	2.65	9.44
Asset Turnover
Asset Turnover	0.3	0.32	0.39	0.44	0.55
Fixed Assets Turnover	2.6	2.57	2.91	3.28	3.88
Receivables Turnover (Average Receivables)	7.86	11.13	13.82	12.19	11.86
Inventory Turnover (Average Inventory)	4.65	5.15	5.32	5.8	5.99
Short Term Liquidity
Current Ratio	2.76	2.38	2.32	2.15	2.43
Quick Ratio	2.42	1.93	1.91	1.76	1.97
Operating Cash Flow to Current Liabilities	-0.2	-0.54	0.3	0.29	0.77
Days Sales Outstanding (Average Receivables)	46.46	32.81	26.4	30.02	30.78
Days Outstanding Inventory (Average Inventory)	78.47	70.93	68.55	63.14	60.93
Average Days Payable Outstanding	40.08	44.33	42.29	35.21	49.03
Cash Conversion Cycle (Average Days)	84.85	59.41	52.66	57.94	42.68
Long Term Solvency
Total Debt/Equity	70.87	80.75	81.6	115.55	105.57
Total Debt / Total Capital	41.48	44.68	44.93	53.61	51.36
LT Debt/Equity	70.11	79.72	78.94	103.67	103.91
Long-Term Debt / Total Capital	41.03	44.1	43.47	48.09	50.55
Total Liabilities / Total Assets	49.32	51.13	51.4	59.48	59.03
EBIT / Interest Expense	-37	-31.62	-15.88	-7.1	-3.81
EBITDA / Interest Expense	-25.29	-19.28	-2.9	2.4	2.88
(EBITDA - Capex) / Interest Expense	-32.59	-30.21	-9.29	-2.63	-0.54
Total Debt / EBITDA	-5.1	-6.49	-45.47	42.73	22.34
Net Debt / EBITDA	-2.91	-4.82	-31.69	26.75	13.83
Total Debt / (EBITDA - Capex)	-3.96	-4.14	-14.21	-39.08	-119.76
Net Debt / (EBITDA - Capex)	-2.26	-3.08	-9.9	-24.46	-74.18
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	18.49	17.95	19.93	10.36	17.69
Gross Profit, 1 Yr. Growth %	15.06	15.41	22.23	8.88	17.94
EBITDA, 1 Yr. Growth %	21.38	-16.69	-75.85	-122.57	209.72
EBITA, 1 Yr. Growth %	21.47	-11.8	-58.61	-55.4	-44.71
EBIT, 1 Yr. Growth %	18.3	-9.82	-50.26	-37.9	-21.72
Earnings From Cont. Operations, 1 Yr. Growth %	-27.68	4.68	-67.26	403.97	-79.79
Net Income, 1 Yr. Growth %	-27.68	4.68	-67.26	403.97	-79.79
Normalized Net Income, 1 Yr. Growth %	4.97	-5.15	-53.86	-39.36	-22.05
Diluted EPS Before Extra, 1 Yr. Growth %	-36.21	1.71	-67.95	393.27	-80.27
Accounts Receivable, 1 Yr. Growth %	-7.09	-27.05	28.84	22.27	19.96
Inventory, 1 Yr. Growth %	13.8	12.63	7.79	27.38	2.35
Net Property, Plant and Equip., 1 Yr. Growth %	27.75	10.26	-1	-2.69	1.41
Total Assets, 1 Yr. Growth %	35.73	-6.85	3.93	-8.39	-1.14
Tangible Book Value, 1 Yr. Growth %	-798.17	21.8	-11.67	-12.42	-8.95
Common Equity, 1 Yr. Growth %	51.53	-10.17	3.36	-23.62	-0.05
Cash From Operations, 1 Yr. Growth %	-174.91	118.67	-169.83	34.86	133.42
Capital Expenditures, 1 Yr. Growth %	108.62	57.96	-42.09	9.5	-0.98
Levered Free Cash Flow, 1 Yr. Growth %	-106.53	-2.08T	-133.39	-38.78	454.55
Unlevered Free Cash Flow, 1 Yr. Growth %	-111.13	-1.52T	-139.58	-29.69	313.46
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	42.01	18.22	18.94	15.05	13.97
Gross Profit, 2 Yr. CAGR %	40.84	15.23	18.77	16.12	13.32
EBITDA, 2 Yr. CAGR %	66.4	0.6	-56.09	-77.01	-16.39
EBITA, 2 Yr. CAGR %	65.1	3.54	-40.67	-57.57	-50.35
EBIT, 2 Yr. CAGR %	71.61	3.32	-34.07	-45.01	-30.28
Earnings From Cont. Operations, 2 Yr. CAGR %	67.19	-12.99	-41.46	28.46	0.93
Net Income, 2 Yr. CAGR %	67.19	-12.99	-41.46	28.46	0.93
Normalized Net Income, 2 Yr. CAGR %	28.9	-0.2	-34.9	-47.64	-29.31
Diluted EPS Before Extra, 2 Yr. CAGR %	46.33	-19.45	-42.9	25.66	-1.39
Accounts Receivable, 2 Yr. CAGR %	28.91	-17.67	-3.05	25.51	21.11
Inventory, 2 Yr. CAGR %	30.42	13.21	10.19	17.18	14.18
Net Property, Plant and Equip., 2 Yr. CAGR %	14.42	19.51	5.09	-1.85	-0.66
Total Assets, 2 Yr. CAGR %	38.09	12.44	-1.61	-2.43	-4.84
Tangible Book Value, 2 Yr. CAGR %	323.5	190.14	3.32	-12.04	-10.7
Common Equity, 2 Yr. CAGR %	21.68	16.67	-3.64	-11.15	-12.63
Cash From Operations, 2 Yr. CAGR %	-4.31	27.98	23.57	-2.96	77.42
Capital Expenditures, 2 Yr. CAGR %	-11.32	81.53	-4.36	-20.37	4.13
Levered Free Cash Flow, 2 Yr. CAGR %	-79.43	13.87	7.64	-55.45	75.26
Unlevered Free Cash Flow, 2 Yr. CAGR %	-69.09	25.94	6.97	-48.06	71.73
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	57.25	33.49	18.79	16.01	15.92
Gross Profit, 3 Yr. CAGR %	57.04	31.79	17.52	13.61	16.72
EBITDA, 3 Yr. CAGR %	55.03	32.13	-37.48	-64.83	-45.3
EBITA, 3 Yr. CAGR %	55.8	33.96	-23.73	-46.06	-53.66
EBIT, 3 Yr. CAGR %	62.83	38.49	-19.03	-35.37	-38.14
Earnings From Cont. Operations, 3 Yr. CAGR %	50.38	43.03	-37.18	19.99	-30.65
Net Income, 3 Yr. CAGR %	50.38	43.03	-37.18	19.99	-30.65
Normalized Net Income, 3 Yr. CAGR %	56.84	16.37	-22.83	-36.42	-39.09
Diluted EPS Before Extra, 3 Yr. CAGR %	34.36	29.62	-40.75	17.16	-32.22
Accounts Receivable, 3 Yr. CAGR %	68.44	6.63	-4.42	4.74	23.63
Inventory, 3 Yr. CAGR %	38.94	24.2	11.38	15.64	12.01
Net Property, Plant and Equip., 3 Yr. CAGR %	45.92	13.54	12.68	2.43	-0.77
Total Assets, 3 Yr. CAGR %	63.69	21.1	9.53	-3.93	-2
Tangible Book Value, 3 Yr. CAGR %	18.37	178.61	94.67	-2.22	-11.02
Common Equity, 3 Yr. CAGR %	70.71	9.97	12.05	-10.83	-7.6
Cash From Operations, 3 Yr. CAGR %	14.04	26.04	4.58	27.23	30.02
Capital Expenditures, 3 Yr. CAGR %	-3.29	7.5	24.04	0.05	-14.37
Levered Free Cash Flow, 3 Yr. CAGR %	-53.67	-5.71	-23.68	-10.82	-0.15
Unlevered Free Cash Flow, 3 Yr. CAGR %	-49.28	10.79	-14.38	-7	4.2
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	77.83	50.94	40.63	25.78	16.84
Gross Profit, 5 Yr. CAGR %	89.05	51.74	40.44	23.81	14.76
EBITDA, 5 Yr. CAGR %	26.4	32.73	-5.6	-33.95	-29.77
EBITA, 5 Yr. CAGR %	28.59	34.86	6.66	-15	-35.76
EBIT, 5 Yr. CAGR %	32.43	39.32	14.13	-3.88	-23.73
Earnings From Cont. Operations, 5 Yr. CAGR %	28.93	40.37	3.11	37.01	-24.06
Net Income, 5 Yr. CAGR %	28.93	40.37	3.11	37.01	-24.06
Normalized Net Income, 5 Yr. CAGR %	32.21	41.09	11.04	-15.1	-25.49
Diluted EPS Before Extra, 5 Yr. CAGR %	16.3	29.02	-4.59	28.05	-27.36
Accounts Receivable, 5 Yr. CAGR %	90.99	43.01	35.05	13.81	5.07
Inventory, 5 Yr. CAGR %	72.71	35.36	26.63	21.34	12.49
Net Property, Plant and Equip., 5 Yr. CAGR %	82.02	60.5	28.32	7.37	7.14
Total Assets, 5 Yr. CAGR %	77.72	59.75	33.54	11.08	3.54
Tangible Book Value, 5 Yr. CAGR %	25.82	20.66	11.87	75.39	42.53
Common Equity, 5 Yr. CAGR %	58.82	42.36	35.8	0.98	1.44
Cash From Operations, 5 Yr. CAGR %	-4.7	25.53	17.76	13.52	29.2
Capital Expenditures, 5 Yr. CAGR %	55.67	34.63	-3.72	-4.66	15.65
Levered Free Cash Flow, 5 Yr. CAGR %	-30.76	23.08	-7.54	-29.36	6.42
Unlevered Free Cash Flow, 5 Yr. CAGR %	-26.29	22.64	-5.97	-17.66	13.11